期刊文献+

鼻咽癌患者外周血单个核细胞Fas和FasL的表达及其意义

The Expression and Significance of Fas and FasL on Peripheral Blood Mononuclear Cell of Patients with Nasopharyngeal Carcinoma
下载PDF
导出
摘要 目的:研究凋亡相关基因Fas和FasL在鼻咽癌患者诱导化疗前后外周血单个核细胞中表达水平的变化,探讨其在鼻咽癌发生、发展中的作用及意义。方法:采用流式细胞仪对38例鼻咽癌患者诱导化疗前后及15例正常健康对照组外周血单个核细胞中的Fas和FasL表达进行检测,并结合临床资料进行分析。结果: ( 1 )鼻咽癌患者外周血单个核细胞中Fas、FasL的表达明显高于正常健康对照组(P<0.05);Ⅲ+Ⅳ期患者的表达明显高于Ⅱ期患者(P<0.05)。(2)T3+4期患者外周血单个核细胞Fas表达明显高于T1+2期患者(P<0.05),而其FasL的表达稍高于T1+2期患者(P>0.05)。(3)N1 期患者的Fas表达明显高于N0 期患者(P<0.05),而其FasL的表达稍高于N0 期患者(P>0.05);N2+3期患者的Fas表达明显高于N1期(P<0 .05),而其FasL表达稍高于N0 期和N1 期(P>0.05)。(4)鼻咽癌患者经诱导化疗后,其Fas表达明显增高(P<0.05),FasL表达稍有增高(P>0.05)。结论:外周血单个核细胞Fas、FasL表达水平与鼻咽癌发生、增殖、局部转移有关,对其进行检测可作为鼻咽癌的诊断及病期判断的辅助指标。 Objective:To study the expression and significance of relevant apoptosis genes, Fas and FasL, on peripheral blood mononuclear cells (PBMC) of patients with nasopharyngeal carcinoma (NPC) before and after the induction chemotherapy, and to investigate their function and clinical value in occurrence, development and treatment of NPC. Methods:Expression of Fas and FasL on PBMC of 38 patients with NPC before and after the induction chemotherapy and 15 normal healthy controls were tested with flow cytometry, and analysed with clinical information. Results:①The expression of Fas and FasL on PBMC in NPC patients was much higher than that in normal healthy controls ( P 〈0. 05 ). The expression of Fas and FasL on PBMC in NPC patients of stage Ⅲ + Ⅳ were much higher than that in stage Ⅱ ( P 〈 0. 05 ). ②The expression of Fas on PBMC in NPC patients of Stage T3 ,4 was much higher than that in stage T1 ,2 ( P 〈 0. 05 ) , but there was no obvious change in expression of FasL ( P 〉 0. 05 ). ③ The expression of Fas on PBMC in NPC patients of stage N1 was much higher than that in stage NO ( P 〈 0. 05 ), there was no obvious change in expression of FasL ( P 〉 0. 05 ). The expression of Fas on PBMC in NPC patients of stage N2+3 was much higher than that in N1 (P 〈0. 05) , but there was no obvious change in expression of FasL ( P 〉 0. 05 ). ④For NPC patients received induction chemotherapy, the expression of Fas increased obviously compared with it before the chemotherapy ( P 〈 0. 05) , there was no obvious change in expression of FasL ( P 〉 0. 05 ). Conclusion :The expression of Fas and FasL on PBMC shows certain significance for occurrence, multiplication and local metastasis of NPC. It can also help diagnose of NPC and judge its stage.
作者 吴伟莉 金风
出处 《临床肿瘤学杂志》 CAS 2005年第2期120-123,共4页 Chinese Clinical Oncology
关键词 鼻咽癌 外周血单个核细胞 Fas/FasL基因/表达 流式细胞仪 Nasopharyngeal carcinoma Peripheral blood mononuclear cell(PBMC) Fas/FasL gene/expression Flow cytometry
  • 相关文献

参考文献9

  • 1Kerr JF, Winterford CM, Harmon BV. Apoptosis: Its significance in cancer and cancer therapy [J]. Cancer, 1994,73(8):2013-2026.
  • 2Weller M, Malipiero C, Bensing-Eh1 A, et al. Fas/APO-1 gene transfer for human malignant glioma [J].Cancer Res, 1995,55(13):2936-2944.
  • 3Nagata S, Colstein P. The Fas death factor [J]. Science, 1995,267(10):1449-1456.
  • 4Papoff G, Cascino I, Eramo A, et al. An N-terminal domain share by Fas/APO-1(CD95) soluble variants prevents cell death in vitro [J]. J Immunol, 1996,156(12):4622-4630.
  • 5谢家印,孙贵银.Fas及其配体与肿瘤免疫[J].国外医学(临床生物化学与检验学分册),2001,22(2):79-80. 被引量:4
  • 6Tanaka M, Suda T, Haza K, et al. Fas ligand in human serum [J]. Nat Med, 1996,2(3):317-322.
  • 7O'Connel J, Bennett MW, O'Sullivan GC, et al. The fas counterattact:cancer as a site of immune privilege [J]. Immunol Today, 1999,20:46-52.
  • 8覃玉桃,刘文其,王仁生.鼻咽癌患者血清可溶性Fas水平变化及其意义[J].中国肿瘤临床,2004,31(4):208-209. 被引量:6
  • 9刘忠文,肖娟,游泳,邹萍.化疗药物诱导白血病细胞凋亡对Fas/FasL途径依赖性的研究[J].中华血液学杂志,2002,23(1):39-40. 被引量:6

二级参考文献12

  • 1钟建明,曾毅,廖建,李秉钧,潘文俊,严壮南,韦继能,王培中,黎而介.Epstein-Barr病毒IgA/VCA抗体变动规律和鼻咽癌发病的关系[J].中华实验和临床病毒学杂志,1996,10(3):225-228. 被引量:19
  • 2曾毅 刘育希 等.应用免疫酶法和免疫放射自显影法普查鼻咽癌[J].中华肿瘤杂志,1979,1(2):81-82.
  • 3Nakamura S,Takeshima I,Nakamura Y,et al.Anti-Fas IgM monoclonal antibody enhances apoptosis induced by low-dose cytosine arabinoside[].Anticancer Research.1999
  • 4Friesen C,Herr I,Krammer PH,et al.Involvement of the CD95 (Apo-1/Fas)receptor/ligand system in drug-induced apoptosis in leukemia cells[].Nature Medicine.1996
  • 5Landowski TH,Shain KH,Oshiro MM,et al.Myeloma cells selected for resistence to CD95-mediated apoptosis are not cross-resistant to cytotoxic drugs: evidence for independent mechanisms of caspase activation[].Blood.1999
  • 6Dirks W,Schone S,Uphoff C,et al.Expression and function of CD95(Fas/Apo-1)in leukemia-lymphoma tumor lines[].British Journal of Haematology.1997
  • 7Younes A,Snell V,Consoli U,et al.Elevated levels of biologically active soluble CD40 ligand in the serum of patients with chronic lymphocytic leukemia[].British Journal of Haematology.1998
  • 8刘陶文,黎金庆,周润华,莫东华,刘健,唐超生.急性白血病患者血浆可溶性Fas受体的水平及其意义[J].临床血液学杂志,1999,12(2):60-62. 被引量:4
  • 9袁红.Fas/FasL与凋亡研究进展[J].国外医学(生理病理科学与临床分册),2000,20(1):26-29. 被引量:26
  • 10仇生龙,彭志海,王裕发,黄锦湫.大肠癌患者血清可溶性Fas(sFas)水平表达[J].肿瘤,2000,20(3):195-197. 被引量:8

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部